Evidence map›Paper›PMID 25247435›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2014

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

Vivek Naranbhai, Dhayendre Moodley, Tsungai Chipato, Lynda Stranix-Chibanda, Clemensia Nakabaiito, Moreen Kamateeka, Philippa Musoke, Karim Manji, Kathleen George, Lynda M Emel and 8 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03092817 phase3completednot on this mapstarted 2017, after this paper: background citation

A Randomized Double Blind Placebo Controlled Trial of Adjunctive Dexamethasone for the Treatment of HIV-infected Adults With Tuberculous Meningitis

TypeinterventionalSponsorOxford University Clinical Research Unit, VietnamRan2017 to 2023Enrolled520ConditionsTuberculosis, Tuberculous Meningitis, Drug-Induced Liver Injury, HIVArmsDexamethasone, Placebo
NCT03100786 phase3completednot on this mapstarted 2018, after this paper: background citation

A Randomized Double Blind Placebo Controlled Non-inferiority Trial of Adjunctive Dexamethasone for the Treatment of HIV-uninfected Adults With Tuberculous Meningitis Stratified by Leukotriene A4 Hydrolase Genotype

TypeinterventionalSponsorOxford University Clinical Research Unit, VietnamRan2018 to 2024Enrolled702ConditionsTuberculosis, Tuberculous Meningitis, Drug-Induced Liver InjuryArmsDexamethasone, Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Human Immunology of Tuberculosis.Microbiology spectrum · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 6 countries.

Vivek Naranbhai*Wellcome Trust Centre for Human Genetics Jenner Institute-Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; †Department of Obstetrics and Gynaecology, Center for the AIDS Programme of Research in South Africa, and Women's Health and HIV Research Unit, University of KwaZulu Natal, Durban, South Africa; ‡University of Zimbabwe College of Medicine Harare, Harare, Zimbabwe; §Department of Obstetrics and Gynaecology, Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda; ‖Department of Paediatrics, Makerere University, Kampala, Uganda; ¶Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; #FHI 360, Research Triangle Park, School of Medicine, Durham, NC; **School of Medicine, Johns Hopkins University, Baltimore, MD; and ††Maternal Adolescent and Child Health, University of the Witwatersrand, Johannesburg, South Africa.
Dhayendre Moodley
Tsungai Chipato
Lynda Stranix-Chibanda
Clemensia Nakabaiito
Moreen Kamateeka
Philippa Musoke
Karim Manji
Kathleen George
Lynda M Emel
Paul Richardson
Philip Andrew
MaryGlenn Fowler
Helen Fletcher
Helen McShane
Hoosen M Coovadia
Adrian V S Hill
HPTN 046 Protocol Team
Johns Hopkins University · USUniversity of Oxford · GBFamily Health International 360 · USUniversity of Zimbabwe · ZWMakerere University · UGMuhimbili University of Health and Allied Sciences · TZUniversity of KwaZulu-Natal · ZAUniversity of the Witwatersrand · ZA

Funding

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
UZ-UCSF CTUUM1AI069436 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZVAVAHERA MIKE CHIRENJE, LYNDA STRANIX-CHIBANDA · 2012 to 2026
$75.9M
HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUPU01AI046749 · NIAID · FAMILY HEALTH INTERNATIONAL · PI CATES, WILLARD · 1999 to 2005
$73.5M
University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials UnitUM1AI069469 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI QUARRAISHA ABDOOL KARIM · 2012 to 2026
$36.4M
NIAID NIH HHS U01 AI046749NIAID NIH HHS U01 AI068632NIAID NIH HHS U01AI068632NIAID NIH HHS U01AI46749NIAID NIH HHS UM1 AI069436NIAID NIH HHS UM1 AI069469Wellcome Trust 095780
6 · The paper itself

Abstract

Recent human studies support historical animal studies that suggested an association between peripheral blood monocyte:lymphocyte (ML) ratio and tuberculosis (TB) disease. To evaluate generalizability of this finding, we modeled the association between peripartum ML ratio and incident TB disease within 18 months postpartum among 1202 HIV-infected women in South Africa, Tanzania, Uganda, and Zimbabwe. The ML ratio was associated with increased risk of TB disease independently to combination antiretroviral therapy, World Health Organization stage, or CD4 count (adjusted hazard ratio = 1.22, 95% confidence interval: 1.07 to 1.4, P = 0.003 per 0.1 unit increase in ML ratio).

Indexed as

Postpartum PeriodAdultAfricaAnimalsFemaleHIV InfectionsHumansLeukocyte CountLymphocytesMonocytesPregnancyRisk AssessmentTuberculosisYoung Adult

Identifiers

PMID25247435
PMCPMC4229408
OpenAlexW204957349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.